Drs. Karl and Spencer discuss how bad the Hims and Hers ad was.

From an outside perspective, the ad may have seemed good.

But when you dig deeper, it was actually really bad.

Listen to learn.

Join Dr. Spencer's new online clinic - Vineyard.

Drs. Karl and Spencer chat with NMN and NAD expert Dr. Charles Brenner all about these supposed longevity supplements.

Learn about NAD metabolism

Whether it's worth supplementing or not with NAD or NMN

Follow Dr. Brenner on Twitter

Drs. Karl and Spencer chat with Dr. Fatima Cody Stanford all about obesity, genetics, and her appearance on 60 minutes.

Does Dr. Sanford believe lifestyle doesn't matter for obesity?

Find out by listening!

Watch Dr. Stanford's 60 minute clip

Join Dr. Spencer's Obesity Clinic

Drs. Karl and Spencer chat about the new Lancet Commission's report on Clinical Obesity along with the new study on high dosed Wegovy.

Learn:

How 7.2 mg of Wegovy (semaglutide) compares to 2.4 mg

What the proposed definitions of clinical and preclinical obesity are

Click here to join Dr. Spencer's new online clinic

Drs. Karl and Spencer chat with Dr. Sowa about her book The Ozempic Revolution.

Learn:

Why she wrote the book.

The top 3 things to know when starting a GLP-1 medicine.

Also hear the top criticism from Drs. Karl and Spencer. You will laugh.

Click here to get the book

If you're on a GLP-1 currently and want to switch to Dr. Spencer's new clinic, Click Here

Drs. Karl and Spencer discuss the concept of "microdosing" GLP-1 receptor agonists along with talk about the new top line results from REDEFINE which studied the new drug CagriSema.

Drs. Karl and Spencer chat with Dr. Lauren Colenso-Semple all about how the menstrual cycle and how it should affect your workout programming.

Should you change your workouts around your menstrual cycle?

Find out by listening!

Check out her instagram

Read her paper on exercise and menstrual cycles

Read her paper on protein synthesis throughout the menstrual cycle

Drs. Karl and Spencer discuss the topline results from Surmount 5 which put Zepbound (tirzepatide) against Wegovy (semaglutide) for weight loss. They also discuss some news around compounded GLP-1s.

Learn:

Weight loss and glycemic differences between tirzepatide and semaglutide

What the FDA is thinking for compounded GLP-1s

If you're not on Dr. Spencer's virtual clinic waitlist, click here